Trial Profile
Cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Nov 2006
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Ramipril (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 01 Nov 2006 New trial record.